tirzepatide po FDA Grants a New Indication for Obesity Management FDA approves tirzepatide, Eli Lilly's
Description
Patients can share first-hand experiences, helping you assess whether the service aligns with your needs

Shipping was a bit slow

The practical timeline: when could you switch

Some people tolerate GLP-1-only stimulation from semaglutide much better than the dual agonist approach
